PATENT CLAIM ANALYSIS

Application Number: 16101861
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "158100"]

Abstract:
Antibodies that bind the apple 2 domain of human coagulation Factor XI and inhibit activation of FXI by coagulation factor XIIa are described.

Claim (Index 34):
A method of treating a thromboembolic disorder or disease in a subject comprising:\n administering to a subject in need thereof a therapeutically effective amount of the antibody or antigen binding fragment of any one of  claims 1 - 26 .

Metadata:
- Claim Count in Document: 122.0
- Percentile: 96.0
- Lexical Diversity: 1.09091
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15409607', '15619620', '16335133', '15906773', '15934526']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7704055759579798
- 35 USC 102 Novelty (BERT): 0.6779614361771003
- Combined Prediction Score: 0.7611611619798918
- Mean Citation Score: 558.16293
- Max Citation Score: 887.4425699999997
- Similarity Product: 640.3641145161757

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test